Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium

Regulatory Peptides

Volumn 117, Issue 1, 2004, Pages 3-10

  Tang, Yao Liang ^a   Zhao, Qiang ^b   Zhang, Y Clare ^a   Cheng, Leilei ^b   Liu, Mingya ^b   Shi, Jianhui ^b   Yang, Yin Zeng ^b   Pan, Chuizhen ^b   Ge, Junbo ^b   Phillips, M Ian ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b FUDAN UNIVERSITY   (China)

^c ADM200 ^*  (United States)

Author keywords

Marrow stromal cells; Myocardial infarction; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY OCCLUSION; ARTICLE; AUTOTRANSPLANTATION; BLOOD FLOW; CELL DIFFERENTIATION; CELL REGENERATION; CELL SECRETION; CONTROLLED STUDY; DENSITY; DONOR; ENDOTHELIUM CELL; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; IMPLANTATION; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SAFETY; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 0346995399     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.09.005     Document Type: Article

References (28)

1. Lenfant C. NHLBI at 50: reflections on a half-century of research on the heart, lungs, and blood. National Heart, Lung, and Blood Institute, Interview by Charles Marwick. JAMA. 280(24):1998;2062-2064.
2. Koransky M.L., Robbins R.C., Blau H.M. VEGF gene delivery for treatment of ischemic cardiovascular disease. Trends Cardiovasc. Med. 12(3):2002;108-114.
3. Maillard L., Peycher P., Fichaux O., Vincentelli-Djeffal D. Gene therapy with VEGF. Presse Med. 29(31):2000;1731-1737.
4. Carlo-Stella C., Mangoni L., Rizzoli V. Biology and clinical applications of long-term bone marrow cultures. Int. J. Artif. Organs. 16(Suppl. 5):1993;76-79.
5. Scorsin M., Hagege A., Vilquin J.T., Fiszman M., Marotte F., Samuel J.L.et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J. Thorac. Cardiovasc. Surg. 119(6):2000;1169-1175.
6. Abbott J.D., Giordano F.J. Stem cells and cardiovascular disease. J. Nucl. Cardiol. 10(4):2003;403-412.
7. Graham R.M., Bishopric N.H., Webster K.A. Gene and cell therapy for heart disease. IUBMB Life. 54(2):2002;59-66.
8. Menasche P. Cell therapy of heart failure. C.R., Biol. 325(6):2002;731-738.
9. Murohara T. Angiogenic cell therapy. Nippon Rinsho. 61(5):2003;871-880.
10. Sylven C. Gene therapy and cell therapy can be revolutionary for cardiology. An alternative in threatening heart failure after myocardial infarction. Lakartidningen. 98(7):2001;650-652.
11. Kim E.J., Li R.K., Weisel R.D., Mickle D.A., Jia Z.Q., Tomita S.et al. Angiogenesis by endothelial cell transplantation. J. Thorac. Cardiovasc. Surg. 122(5):2001;963-971.
12. Matsunaga T., Warltier D.C., Tessmer J., Weihrauch D., Simons M., Chilian W.M. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am. J. Physiol., Heart Circ. Physiol. 285(1):2003;H352-H358.
13. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T.et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 100(Suppl. 19):1999;II247-II256.
14. Wang J.S., Shum-Tim D., Chedrawy E., Chiu R.C. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J. Thorac. Cardiovasc. Surg. 122(4):2001;699-705.
15. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Amano K., Iba O.et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler. Thromb. Vasc. Biol. 22(11):2002;1804-1810.
16. Edelberg J.M., Tang L., Hattori K., Lyden D., Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90(10):2002;E89-E93.
17. Besse A., Trimoreau F., Praloran V., Denizot Y. Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells. Cytokine. 12(5):2000;522-525.
18. Su H., Lu R., Kan Y.W. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc. Natl. Acad. Sci. U. S. A. 97(25):2000;13801-13806.
19. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R.et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 104(9):2001;1046-1052.
20. Fuchs S., Baffour R., Zhou Y.F., Shou M., Pierre A., Tio F.O.et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 37(6):2001;1726-1732.
21. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 98(9):2001;2615-2625.
22. Eliopoulos N., Al Khaldi A., Beausejour C.M., Momparler R.L., Momparler L.F., Galipeau J. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells. Gene Ther. 9(7):2002;452-462.
23. Huss R. Perspectives on the morphology and biology of CD34-negative stem cells. J. Hematother. Stem. Cell Res. 9(6):2000;783-793.
24. Tomanek R.J., Schatteman G.C. Angiogenesis: new insights and therapeutic potential. Anat. Rec. 261(3):2000;126-135.
25. Gulbins H., Schrepfer S., Uhlig A., Goldemund A., Oberhoffer M., Reichenspurner H.et al. Myoblasts survive intracardiac transfer and divide further after transplantation. Heart Surg. Forum. 5(4):2002;340-344.
26. Saito T., Kuang J.Q., Lin C.C., Chiu R.C. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J. Thorac. Cardiovasc. Surg. 126(1):2003;114-123.
27. Katsumatal N., Ma X., Higuchi H. Protective effect of diltiazem against ischemia-induced decreases in regional myocardial flow in rat heart. Eur. J. Pharmacol. 398(1):2000;83-91.
28. Takahashi N., Reinhardt C.P., Marcel R., Leppo J.A. Correlations between uptake of technetium-99m Q12 and thallium-201: myocardial perfusion and viability in a model of acute coronary reperfusion. J. Nucl. Med. 39(1):1998;159-165.